Wed, Jul 23, 2014, 8:47 AM EDT - U.S. Markets open in 43 mins.

Recent

% | $
Click the to save as a favorite.

Market Vectors Junior Gold Mine Message Board

jrdelane 2047 posts  |  Last Activity: 6 hours ago Member since: Dec 5, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Thanks VJ, see all winners on other side of results! To the top!

    Sentiment: Strong Buy

  • Reply to

    Back on track?

    by turnermuseum 7 hours ago

    Totally back, ride em, buck 'em, see how shorts do all heading for the exits at the same time. Funny.

    Sentiment: Strong Buy

  • Reply to

    Very active AH trading, up 5% to 3.04

    by jrdelane 10 hours ago

    PBYI's news was on their phase III trial, and with Neuvax being in it's phase 3 trial, people saw what this did on results and piled on GALE, this is the beginning of the next wave of short covering, if they aren't scared yet, they sure ought to be. The early share rise waned in the afternoon after AFstain did his usual panning of GALE's licensing of Zuplenz. Very short term effect this time, Piper Jaffray liked the licensing, said it makes sense since the same doctors who prescribe Abstral will be prescribing Zuplenz. I think it's brilliant!

    Sentiment: Strong Buy

  • Reply to

    Company news

    by samyarabian Jul 21, 2014 12:26 PM

    For sure this is as low as psychology has been for this stock in the last two years since I was coming here. At a rock bottom price of 2.21, and sentiment has us going lower yet, the YMB is as crowded with ignored posters as I've ever seen it, and I am down to the last 5% of my shares, which I am seriously considering dumping. Even at 2.20 if I were to sell here, I can identify many names that have great upside and nothing holding them down to the floorboards like ATRS. I won't bother to name them but am holding names that people here have laughed at that are doing fine while this one is scraping its chin on the pavement.

    Sentiment: Hold

  • jrdelane jrdelane 10 hours ago Flag

    Waiting, reminds me of Nupathe before the TEVA buyout was announced, quiet, doldrums, then BAM we got it.

    Sentiment: Strong Buy

  • Reply to

    FORM 4 AGAIN.

    by fbi4hire 15 hours ago
    jrdelane jrdelane 10 hours ago Flag

    These are automatic sales to cover tax payments. They are calling attention to what they aren't selling with these forms, letting us know they are holding the big share lots for what's coming.

    Sentiment: Strong Buy

  • Reply to

    New Market Cap - $4 Billion+++++

    by kelwoods10 12 hours ago
    jrdelane jrdelane 10 hours ago Flag

    Check on our stock AH, up strongly, did what it should have done in the regular session.

    Sentiment: Strong Buy

  • What happened after hours is PBYI, and maybe investors seeing that and understanding GALE is way undervalued after a much tempered regular session, a lot of folks got excited and went shopping for GALE shares?

    Sentiment: Strong Buy

  • Reply to

    question

    by ballardrow 20 hours ago
    jrdelane jrdelane 20 hours ago Flag

    These deals can take months to hammer out all the terms and come to a binding agreement, so they didn't mention it during the earning call, and likely they weren't ready, if there is a deal at all. I am starting to think nothing will happen with AGN, although I hope I'm wrong.

  • Reply to

    Company news

    by samyarabian Jul 21, 2014 12:26 PM
    jrdelane jrdelane Jul 22, 2014 1:51 AM Flag

    The longer Hobbs waits to address investors, the greater the expectation builds toward his delivering something of real magnitude. Yet we haven't heard squat. His imprint on this company has yet to be felt, maybe the BOD has only decided to use him as a placeholder until such time as they hire a new leader. I believe Wotten was asked to step down as others here have suggested, glad for that but we do need leadership and without it shares continue to fade.

    Sentiment: Hold

  • Reply to

    Back up the truck?

    by jrdelane Jul 21, 2014 8:08 PM
    jrdelane jrdelane Jul 21, 2014 10:20 PM Flag

    I've seen it posted, that Buffett said "The Stock Market is the transfer of wealth from the impatient-- to the patient" and if he actually said that, which I tried to verify, then he's right.

  • Reply to

    Maybe best not to take Nova at face value

    by cotheo Jul 21, 2014 4:09 PM
    jrdelane jrdelane Jul 21, 2014 9:39 PM Flag

    I've had him on ignore since coming here, why wouldn't everyone, he's made a shitpile out of this board!

    Sentiment: Strong Buy

  • jrdelane by jrdelane Jul 21, 2014 8:08 PM Flag

    I am not, but I'm sure others here are. Actually, if you buy here, I think you will prosper. Profitability is in sight I believe, certainly within the year and with other catalysts enumerated many times by others here on the horizon, it's a good bet from here. I am already fully subscibed elsewhere, good luck. I hold with many of you awaiting the inevitable run up, back to water level. Originally I had forecast a hold until 2017, any projections of price out that far? $15?

    Sentiment: Hold

  • Reply to

    16 days still no data

    by gavin020207 Jul 17, 2014 12:41 AM
    jrdelane jrdelane Jul 21, 2014 11:02 AM Flag

    I was at the Angels baseball game yesterday against the Mariners, and it ended on the last pitch when the Angel's scored the winning run in the bottom of the 9th inning. To use an analogy, here we are in the early innings of the game, and you are wanting to score winning runs now! Let the game play out, this one has got the right elements for success, admit it or you wouldn't be here. Just can't force it, anyone ever tell you it takes patience to invest in biotech stocks?

  • Reply to

    Tappy any red flags in ATRS investment thesis?

    by nkkjuas Jul 20, 2014 10:35 PM
    jrdelane jrdelane Jul 21, 2014 10:44 AM Flag

    Tappy, I would agree the stock is undervalued, to a greater extent than at any previous time I have been invested here. To think that we're now halved from the few times it has rallied to $5.00 is reflective of the harsh treatment investors have assigned to the stock. I have resisted adding more to this one, in fact took some shares to sale at 2.54 but still holding a small position. Eventually, this will return to us, one has to think.

    Sentiment: Hold

  • Reply to

    Good week

    by green_pumper Jul 20, 2014 10:42 PM
    jrdelane jrdelane Jul 21, 2014 12:39 AM Flag

    They don't have to make huge money to have this be a great investment for the rest of us. There are other significant tutes that will hold through to BO, and we should prosper even without Deerfield's cash drawer.

    Sentiment: Strong Buy

  • Reply to

    SEC investigating 10 Hedge Funds, bashers next?

    by jrdelane Jul 19, 2014 7:06 PM
    jrdelane jrdelane Jul 19, 2014 10:51 PM Flag

    I agree with you, was just a touch of wishful thinking, smiling as I wrote it, SEC needs to go after big guys as they have limited resources for the individual insignificant bashers. It does give me a sense of hope that we SE these occasional enforcement actions.

    Sentiment: Strong Buy

  • "The U.S. Securities and Exchange Commission has been seeking information on 10 registered broker dealers as part of an ongoing investigation into high-frequency trading strategies, according to an internal SEC document reviewed by Reuters.
    The firms listed are Allston Trading LLC; Hudson River Trading LLC; Jump Trading LLC; Latour Trading LLC, which is an affiliate of Tower Trading; Merrill Lynch, Pierce, Fenner & Smith, owned by Bank of America Group; Octeg LLC, which has been merged into a unit of KCG Holdings Inc; Tradebot Systems Inc; Two Sigma Investments LLC; Two Sigma Securities LLC; and Virtu Financial.
    They are all some of the largest trading firms in the U.S. Allston and Jump are both based in Chicago. Hudson River, Latour, Merrill, Two Sigma, and Virtu are headquartered in New York. KCG is in Jersey City, New Jersey, and Tradebot is based in Kansas City, Missouri.
    Jump, Latour, Bank of America, Hudson River, Tradebot and KCG declined to comment. The other firms did not immediately respond to a request for comment.
    Their number and the open-ended quest for information shows that the SEC is casting a wide net as it looks to unearth wrongdoing in the marketplace. A number of government agencies, including the SEC, New York State Attorney General Eric Schneiderman's office, the Commodity Futures Trading Commission and the Federal Bureau of Investigation have said they had active probes into high-speed and automated trading.
    The SEC has been seeking evidence of abuse of order types, as well as traditional forms of abusive trading like "layering" or "spoofing" and other issues relating to high-frequency trading that might be violations of the law, SEC Director of Enforcement Andrew Ceresney told Reuters in May.
    Spoofing and layering are tactics where traders places orders that they cancel before they are executed to create the false impression of demand, aiming to trick others into buying or selling a stock at unreal..."

  • And Sovaldi is far from the only new treatment to roll out with a hefty price tag. Roche's ($RHHBY) latest breakthrough cancer med, the HER2-positive breast cancer treatment Kadcyla, made its debut at $94,000 per treatment course, and Bristol-Myers Squibb's ($BMS) melanoma treatment Yervoy runs more than $100,000.

    When Neuvax is approved the revenues to Gale will be astronomical as it reaches market acceptance.

    Sentiment: Strong Buy

  • Reply to

    With ATRS every time...

    by jrdelane Jul 11, 2014 12:38 PM
    jrdelane jrdelane Jul 19, 2014 1:52 PM Flag

    Correct you were, close anyway!

    Sentiment: Hold

GDXJ
42.89-1.25(-2.83%)Jul 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.